Medytox (KRX: 086900)

Medytox is a corporation based in Seoul, South Korea. Established in 2000, the company is engaged in the development, manufacture, and marketing of biopharmaceuticals. Its main product is type-A botulinum toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases, and infantile cerebral palsy. The company provides its products under the brand names of Neuronox, Siax, and others. It distributes its products within Korea and to overseas markets, such as Japan, China, Russia, and Europe, among others. The assets are managed by executive management team.